WELL Health Technologies Corp.
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- WELL Health Technologies Corp. (WELL.TO) operates as a practitioner-focused digital healthcare company, owning and operating Canada's largest network of outpatient medical clinics providing primary, allied, diagnostic, specialized, and preventative care services; in the United States, it delivers omni-channel patient services targeting medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. The company offers a comprehensive practitioner enablement platform, including electronic medical records (EMR) such as OSCAR, Juno, Profile (Intrahealth), and Cerebrum (AwareMD); telehealth platforms; practice management software; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions; cybersecurity and patient data privacy tools; digital health apps; ePharma; digital booking; e-Referral; and e-Rx services. Founded in 2010 and headquartered in Vancouver, British Columbia, Canada, WELL primarily serves healthcare providers and patients across Canada, the United States in 19 states, and internationally, supporting over 42,000 providers and tens of millions of patient interactions through its omni-channel model. In recent developments, WELL has accelerated its Canadian clinics acquisition strategy, completing 12 transactions year-to-date through Q3 2025 acquiring CAD 67 million in clinical revenue, surpassing prior-year full-year metrics, with a CAD 235 million pipeline under LOI across 61 clinics; it added over CAD 100 million in annualized revenue from seven cash acquisitions since December 2024. The company reorganized through intra-group transactions, including HealWell divesting polyclinic assets and its Neutro AI scribe platform to WELL Star, alongside forming a 50/50 clinical research joint venture with WELL; WELL Star acquired a healthcare billing company and advanced toward a go-public initiative targeting over CAD 100 million run-rate revenue. WELL continues strategic evaluation of divesting U.S. care delivery assets like Wisp, Circle Medical, and CRH, with multiple advanced discussions underway, while enhancing AI integration and clinic digitization for operational efficiency.
Company News
WELL Health Strengthens Privacy and AI Governance Leadership with Appointment of Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory
WELL Health to Present at The Cantech Investment Conference on October 8 in Toronto
WELL Health Subsidiary WELLSTAR Announces Completion of Amalgamation and Expected Trading Date of "WSTR" on TSXV
WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement
WELL Health Launches WELL Research, an End-to-End Clinical Trial Platform Built on Canada's Largest Outpatient Network
WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
WELL Health Redeems $70 Million 5.50% Convertible Debentures
WELL Health Technologies Q2 Earnings Call Highlights
WELL Health Achieves Record Quarterly Revenue Milestone of $400 Million in Q2-2026, Driven by 32% Revenue Growth of Canadian Patient Services, and Raises 2026 Annual Guidance
WELL Health Strengthens Executive Leadership Team with Appointments of Loreto Grimaldi as Chief Legal Officer and Kaytek Przybylski as Chief Digital & Information Officer
WELL Health to Announce Second Quarter 2026 Financial Results on August 6, 2026
WELL Health Subsidiary WELLSTAR Closes C$50 Million Financing Transaction Ahead of Planned TSXV Listing
WELL Health Closes $150 Million, 5-Year Senior Unsecured Notes Offering
WELL Health Announces Pricing of $150 Million Senior Unsecured Notes Offering
WELL Health Announces Proposed TSXV Listing and Concurrent Financing for WELLSTAR, One of Canada’s Leading Healthcare Software and AI Platforms
WELL Health Announces Proposed TSXV Listing and Concurrent Financing for WELLSTAR, One of Canada's Leading Healthcare Software and AI Platforms
WELL Health Announces Voting Results for Election of Directors
WELL Health Provides a Corporate Update on Circle Medical